Joerns Healthcare partners with MolecuLight for wound imaging technology

Joerns Healthcare announced an exclusive agreement with MolecuLight Corp. to add MolecuLight's fluorescence imaging technology (i:X and DX devices) to its wound management portfolio for point-of-care detection of bacterial burden in wounds.

“We are thrilled to partner with Joerns Healthcare to provide long-term healthcare facilities with access to our imaging platform for their wound care needs.”prnewswire.com

• 1 source
• prnewswire.comJoerns Healthcare Introduces Point-of-Care Imaging to Wound Care Portfolio Through MolecuLight PartnershipMolecuLightOct 19, 2021

Summarized from public sources; check the original articles before acting on it.